FAS and autoimmune lymphoproliferative syndrome: Autoimmune lymphoproliferative syndrome (ALPS) is characterized by nonmalignant organomegaly, immune cytopenia, and an increased risk for lymphoma, as well as mutation in the FAS-mediated apoptotic pathway [1,2,3,4,5,6,7,8,9,10].